[Changes in erythropoiesis in patients with malignant tumors of the ovaries during chemotherapy].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002699:Chlorambucil / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects*; D004906:Erythrocyte Count; D004920:Erythropoiesis / Q000187:drug effects*; D005260:Female; D006454:Hemoglobins; D006801:Humans; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011743:Pyrimidines / Q000009:adverse effects; D013852:Thiotepa / Q000009:adverse effects*
D000970:Antineoplastic Agents; D006454:Hemoglobins; D009588:Nitrogen Mustard Compounds; D011743:Pyrimidines; D002699:Chlorambucil; D003520:Cyclophosphamide; D013852:Thiotepa
Izmeneniia éritropoéza u bol'nykh zlokachestvennymi opukholiiami iaichnikov v protsesse khimioterapii.